Clinical & Translational Immunology最新文献

筛选
英文 中文
Immunological insights into gastric polyps: pathogenesis, inflammation and neoplastic potential 胃息肉的免疫学研究:发病机制、炎症和肿瘤潜能
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-29 DOI: 10.1002/cti2.70092
Kshitija Kale, Pranav S. Renavikar, Anjali D. Amarapurkar
{"title":"Immunological insights into gastric polyps: pathogenesis, inflammation and neoplastic potential","authors":"Kshitija Kale,&nbsp;Pranav S. Renavikar,&nbsp;Anjali D. Amarapurkar","doi":"10.1002/cti2.70092","DOIUrl":"10.1002/cti2.70092","url":null,"abstract":"<p>Gastric polyps are a heterogeneous group of mucosal lesions increasingly detected during routine endoscopy, encompassing entities with distinct pathogenesis, immune landscapes and variable malignant potential. Accumulating evidence highlights the central role of gastric mucosal immunity in driving polyp initiation, progression, and, in select subtypes, neoplastic transformation. This review synthesises current knowledge on the immunopathogenesis of major gastric polyp subtypes, including hyperplastic, fundic gland, adenomatous, neuroendocrine and inflammatory fibroid polyps, with a particular emphasis on the interplay between chronic inflammation, epithelial injury and immune-mediated tissue remodelling. We discuss how <i>Helicobacter pylori</i> infection, autoimmune gastritis, proton pump inhibitor–induced hypergastrinemia and genetic syndromes shape distinct immune microenvironments characterised by specific cytokine profiles, immune cell infiltrates and epithelial responses. Special attention is given to mechanisms linking sustained immune activation to dysplasia and carcinogenesis, including oxidative stress, cytokine-driven proliferation, immune surveillance failure and early engagement of immune checkpoint pathways such as PD-1/PD-L1. Furthermore, we explore emerging diagnostic, prognostic and therapeutic implications of immune profiling in gastric polyps, ranging from <i>H. pylori</i> eradication and chemoprevention to the potential role of immunomodulatory strategies in high-risk lesions. By integrating immunology with histopathology and clinical behaviour, this review provides a comprehensive framework for understanding gastric polyp biology and identifies key gaps and future directions for precision surveillance and immune-targeted prevention of gastric neoplasia.</p>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 4","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70092","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147684103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial transcriptomic analysis of the immune landscape following NBUVB treatment of vitiligo skin NBUVB治疗白癜风皮肤后免疫景观的空间转录组学分析
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-29 DOI: 10.1002/cti2.70080
Abhik Dutta, Divya Gupta, Johan Ajnabi, Binita Dam, Shilpashree P, Colin Jamora
{"title":"Spatial transcriptomic analysis of the immune landscape following NBUVB treatment of vitiligo skin","authors":"Abhik Dutta,&nbsp;Divya Gupta,&nbsp;Johan Ajnabi,&nbsp;Binita Dam,&nbsp;Shilpashree P,&nbsp;Colin Jamora","doi":"10.1002/cti2.70080","DOIUrl":"10.1002/cti2.70080","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Vitiligo is an autoimmune disorder characterised by the presence of depigmented lesions on the skin. The autoreactive cytotoxic T cells at the epidermal-dermal junction of the skin facilitate the targeted destruction of epidermal melanocytes, leading to the development of vitiligo lesions. Narrow-band UVB (NBUVB) phototherapy is a widely used non-invasive treatment that promotes transient repigmentation of lesions. However, the specific effects of NBUVB on skin dermal T cells in vitiligo patients remain largely unexplored. Insights into the mechanism of action of NBUVB phototherapy can guide therapies against cytotoxic T cells, enabling effective and sustained remission of vitiligo lesions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Indian patients with active vitiligo lesions underwent 3 months of NBUVB phototherapy, thereby leading to successful repigmentation of vitiligo lesions. Spatial transcriptomic and histological analyses were employed to investigate the gene expression profiles of dermal T cells at the epidermal-dermal junction, both before and after treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Comprehensive spatial transcriptome analysis of skin dermal T cells revealed that NBUVB phototherapy leads to the overall suppression of inflammatory genes and immune regulatory pathways that are upregulated in vitiligo patients before treatment. Consequently, tissue-resident innate and adaptive immune cells significantly decrease post-UVB phototherapy. Interestingly, we observe an increase in naïve CD4<sup>+</sup> T cells post-UVB phototherapy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>NBUVB phototherapy effectively suppresses the innate and adaptive immune cell populations and immune regulatory pathways while promoting an increase in naïve CD4<sup>+</sup> T cells. These findings underscore a previously unrecognised immunomodulatory role of NBUVB phototherapy in vitiligo patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 4","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147684134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helminths as architects of trained tolerance: implications for human health 作为训练耐受性建筑师的蠕虫:对人类健康的影响
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-22 DOI: 10.1002/cti2.70086
Quinn Moroz, Jorge Lucas Nascimento Souza, Neima Briggs
{"title":"Helminths as architects of trained tolerance: implications for human health","authors":"Quinn Moroz,&nbsp;Jorge Lucas Nascimento Souza,&nbsp;Neima Briggs","doi":"10.1002/cti2.70086","DOIUrl":"https://doi.org/10.1002/cti2.70086","url":null,"abstract":"<p>Helminths infect nearly 2 billion people worldwide and are a major cause of chronic morbidity in low-resource regions. Unlike bacterial and viral pathogens that elicit protective memory, helminths actively remodel host immunity to enable their years-long persistence and reinfection. We put forward the concept of ‘trained tolerance’, which describes the durable yet reversible system-wide immunological programme helminths exert on the host to promote their own survival. In humans, this altered immune set point shapes host responses to concurrent challenges, including cancer immunity, allergy, autoimmunity, coinfections and vaccine effectiveness. Here, we outline research priorities, including defining species-specific immune correlates of protection versus tolerance, integrating longitudinal cohorts and controlled human infection studies with single-cell and spatial profiling, establishing standardised biomarker panels to track immune recalibration after parasite clearance and evaluating the impact of anthelmintic treatment prior to immunisation campaigns to restore germinal centre function and durable protection.</p>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147567928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of SAMHD1 genetic interferonopathy in vitro cGAS抑制剂IMSB301修饰SAMHD1遗传干扰素病外周单核细胞中的干扰素信号传导
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-19 DOI: 10.1002/cti2.70090
Velda X Han, Jessica P Hayes, Lijun Sun, Teresa Mooneyham, Michelle Lorentzos, Hiroya Nishida, Markus J Hofer, Brian Gloss, Ruwani Dissanayake, Xianzhong Lau, Shekeeb S Mohammad, Shrujna Patel, Russell C Dale
{"title":"cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of SAMHD1 genetic interferonopathy in vitro","authors":"Velda X Han,&nbsp;Jessica P Hayes,&nbsp;Lijun Sun,&nbsp;Teresa Mooneyham,&nbsp;Michelle Lorentzos,&nbsp;Hiroya Nishida,&nbsp;Markus J Hofer,&nbsp;Brian Gloss,&nbsp;Ruwani Dissanayake,&nbsp;Xianzhong Lau,&nbsp;Shekeeb S Mohammad,&nbsp;Shrujna Patel,&nbsp;Russell C Dale","doi":"10.1002/cti2.70090","DOIUrl":"https://doi.org/10.1002/cti2.70090","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Aicardi–Goutières syndrome (AGS) is a rare genetic interferonopathy because of aberrant DNA or RNA metabolism that lacks effective disease modifying therapies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Single-cell RNA sequencing was performed on peripheral blood mononuclear cells (PBMCs) obtained from a patient with AGS because of pathogenic biallelic <i>SAMHD1</i> variants to assess baseline gene dysregulation compared to an age- and sex-matched control. The patient and control's PBMCs were incubated with the novel clinical stage cGAS inhibitor IMSB301 for 24 h, followed by evaluation of its effects on <i>in vitro</i> gene expression.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In PBMCs from the patient with <i>SAMHD1</i> mutation, at baseline, the most upregulated enriched pathways were ‘response to virus’ and ‘response to type 1 interferon’; these were also the most downregulated pathways after <i>in vitro</i> IMSB301 treatment. The top five most upregulated genes at baseline were interferon-stimulated genes (ISG) <i>IFIT1, IFIT3, IFI44L, ISG15, OAS1</i>, which were downregulated to control levels after <i>in vitro</i> treatment with IMSB301.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The cGAS inhibitor IMSB301 resulted in specific reduction in interferon signalling <i>in vitro</i> in PBMCs from a patient with <i>SAMHD1</i> mutation, indicating a potential therapeutic role in genetic interferonopathy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70090","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147567421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Ad26-MVA-BN-based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infections 针对HPV16和HPV18相关疾病的基于ad26 - mva - bn的治疗性疫苗在临床前模型和持续HPV感染的女性中具有免疫原性
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-17 DOI: 10.1002/cti2.70089
Selina Khan, Satish Boedhoe, Miranda Baert, Jan Serroyen, Thierry Verbinnen, Ariane Volkmann, Markus Kalla, Katrin Weidner, Mathieu Le Gars, Jerry Sadoff, Michal Sarnecki, Jort Vellinga, Jerome Custers, Gert Scheper, Hanneke Schuitemaker, Roland Zahn
{"title":"An Ad26-MVA-BN-based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infections","authors":"Selina Khan,&nbsp;Satish Boedhoe,&nbsp;Miranda Baert,&nbsp;Jan Serroyen,&nbsp;Thierry Verbinnen,&nbsp;Ariane Volkmann,&nbsp;Markus Kalla,&nbsp;Katrin Weidner,&nbsp;Mathieu Le Gars,&nbsp;Jerry Sadoff,&nbsp;Michal Sarnecki,&nbsp;Jort Vellinga,&nbsp;Jerome Custers,&nbsp;Gert Scheper,&nbsp;Hanneke Schuitemaker,&nbsp;Roland Zahn","doi":"10.1002/cti2.70089","DOIUrl":"https://doi.org/10.1002/cti2.70089","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To develop a therapeutic human papillomavirus (HPV) vaccine capable of intercepting HPV-related cervical disease to reduce the number of new cancer cases and associated deaths.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We previously reported that replication-deficient adenovirus type 26 and 35-based vectors (Ad26, Ad35) expressing a fusion protein of E2, E6 and E7 (E2SH) from HPV16 and HPV18 induced robust HPV-specific T-cell immunity capable of reducing HPV16+ tumors in mice. Here, we assessed immune responses induced by Ad26 and Modified Vaccinia Virus Ankara—strain Bavarian Nordic (MVA-BN) viral vectors expressing E2SH in heterologous vaccination regimens in mice, macaques and a limited number of persistently HPV-infected women (<i>N</i> = 5).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The magnitude and breadth of cellular immune responses were higher in mice that received Ad26.HPV16/18-MVA-BN.HPV16/18 than in those that received Ad26.HPV16/18-Ad35.HPV16/18, all expressing the fusion protein E2SH of HPV16 and HPV18. Sustained and broad antigen-specific systemic T-cell responses against HPV16 and HPV18 proteins were induced in macaques. In the Phase 1/2a trial, a 2-dose heterologous immunisation with Ad26.HPV16 or Ad26.HPV18 in Week 0 and MVA-BN.HPV16/18 in Week 8 induced long-lived antigen-specific cytokine-producing T cells. After Week 8, HPV16/18 infection was no longer detected in 5/5 active vaccines and 1/4 placebo recipients during the study period of approximately 1 year. The small number of vaccinated participants did not allow concluding on the relationship between immune responses and viral clearance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>These data show the ability of Ad26.HPV16/18-MVA-BN.HPV16/18 heterologous regimens to elicit HPV-specific T-cell responses and warrant further clinical studies to evaluate vaccine efficacy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70089","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147566713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypes 对自身抗原LL-37的适应性免疫反应可区分动脉粥样硬化性心血管疾病的表型
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-16 DOI: 10.1002/cti2.70083
Paul C. Dimayuga, Kuang-Yuh Chyu, Jianchang Zhou, Xiaoning Zhao, Janet Wei, Bojan Cercek, Prediman K. Shah
{"title":"Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypes","authors":"Paul C. Dimayuga,&nbsp;Kuang-Yuh Chyu,&nbsp;Jianchang Zhou,&nbsp;Xiaoning Zhao,&nbsp;Janet Wei,&nbsp;Bojan Cercek,&nbsp;Prediman K. Shah","doi":"10.1002/cti2.70083","DOIUrl":"https://doi.org/10.1002/cti2.70083","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Atherosclerosis is the common underlying pathology in atherosclerotic cardiovascular disease (ASCVD) phenotypes of myocardial infarction (MI), stroke or peripheral artery disease (PAD). Single immune cell profiling of atherosclerotic plaques demonstrates a site-specific immune profile associated with the ASCVD phenotype, and LL-37 is a reported autoantigen in atherosclerosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To investigate whether the immune response to LL-37 would be common among different ASCVD phenotypes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Peripheral blood mononuclear cells (PBMCs) and plasma were collected from stable ASCVD patients enrolled within 12 months after MI or stroke or diagnosed with PAD. A subgroup of post-acute patients provided PBMCs at follow-up (14.7 ± 3.6 months). T-cell response to LL-37 was profiled using activation-induced markers. LL-37 IgG, immune complex (IC) levels and subclass were evaluated with ELISA. LDL is a reported binding partner of LL-37 in plasma. Therefore, cross-reactivity of LL-37 IgG-ICs with native LL-37 or LL-37 complexed with LDL (LL-37_LDL) was assessed using immune depletion.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>LL-37 provokes increased CD4<sup>+</sup>CD25<sup>+</sup>CD134<sup>+</sup> T-cell response in stable post-MI patients whereas CD8<sup>+</sup>CD25<sup>+</sup>CD69<sup>+</sup> T cells were reduced in PAD. CD4<sup>+</sup> T-cell response to LL-37 in post-MI patients persisted at follow-up with increased CD4<sup>+</sup>CD25<sup>+</sup>CD69<sup>+</sup>FoxP3<sup>+</sup> T regulatory cells while post-stroke patients had increased CD8<sup>+</sup>CD134<sup>+</sup> T cells. LL-37 IgG-ICs were significantly increased in ASCVD patients with IgG3 subclass reduced in post-MI compared to post-stroke. Immune-depletion showed cross-reactivity of LL-37 IgG-ICs with both native LDL and LL-37_LDL only in post-MI plasma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>LL-37 antigen specific profiling of immune response may differentiate various ASCVD phenotypes and provide mechanistic insight in pathophysiology.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70083","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147566041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation 两例A91V PRF1纯合子突变患者的临床、生物学和细胞学特征
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-15 DOI: 10.1002/cti2.70081
Nicolas Perrard, Claire Poggi, Sébastien Sanges, Bruno Lemarchant, Wadih Abou Chahlah, Louis Terriou, Stéphanie Delangue, Jacques Trauet, Myriam Labalette, Eric Hachulla, Despina Moshous, Guillaume Lefevre, David Launay
{"title":"Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutation","authors":"Nicolas Perrard,&nbsp;Claire Poggi,&nbsp;Sébastien Sanges,&nbsp;Bruno Lemarchant,&nbsp;Wadih Abou Chahlah,&nbsp;Louis Terriou,&nbsp;Stéphanie Delangue,&nbsp;Jacques Trauet,&nbsp;Myriam Labalette,&nbsp;Eric Hachulla,&nbsp;Despina Moshous,&nbsp;Guillaume Lefevre,&nbsp;David Launay","doi":"10.1002/cti2.70081","DOIUrl":"https://doi.org/10.1002/cti2.70081","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Inborn errors of immunity are rare genetic disorders that cause dysfunction of the immune system. Among these, familial haemophagocytic lymphohistiocytosis (FHL) involves defects in the perforin/granzyme pathway, which is essential for regulating immune responses. These conditions predispose individuals to haemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory syndrome. FHL has traditionally been described in paediatric patients with a fatal outcome in the absence of early haematopoietic stem cell transplantation. However, some patients harbouring missense mutations may present with atypical or late-onset symptoms, for which management remains unstandardised. Among these reported variants, the pathogenicity of the A91V <i>PRF1</i> mutation remains the most controversial in the literature.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>We report clinical, biological and cytometric characteristics of two patients with a homozygous <i>PRF1</i> A91V mutation who developed clinical features consistent with FHL2.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>We discuss the latest 2024 classifications to better characterise this group of disorders and their underlying genetic basis, with particular emphasis on atypical presentations and the A91V mutation, which may pose diagnostic and therapeutic challenges.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>A91V <i>PRF1</i> variant appears to represent a risk factor for the development of atypical FHL manifestations under divers triggers.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70081","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147614895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the immune landscape and microenvironmental architecture of IgA nephropathy using single-cell imaging mass cytometry 利用单细胞成像细胞计数技术揭示IgA肾病的免疫景观和微环境结构
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-13 DOI: 10.1002/cti2.70088
Xing Chen, Long Liu, Lijing Yao, Jianxin Shen, Hengyuan Zhang, Leping Shao, Xingxing Yu, Zhijuan Lin, Lu Zhang
{"title":"Unveiling the immune landscape and microenvironmental architecture of IgA nephropathy using single-cell imaging mass cytometry","authors":"Xing Chen,&nbsp;Long Liu,&nbsp;Lijing Yao,&nbsp;Jianxin Shen,&nbsp;Hengyuan Zhang,&nbsp;Leping Shao,&nbsp;Xingxing Yu,&nbsp;Zhijuan Lin,&nbsp;Lu Zhang","doi":"10.1002/cti2.70088","DOIUrl":"https://doi.org/10.1002/cti2.70088","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The heterogeneity in the pathology of IgA nephropathy (IgAN) represents a significant gap in current research, emphasising the need for individualised treatment strategies. The role of the glomerular microenvironment in driving IgAN heterogeneity remains largely unknown.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study employed Imaging Mass Cytometry (IMC) to analyse 34 primary IgAN renal biopsies. A panel of 35 protein markers was used to identify and characterise 17 cell clusters.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Immune cells composed of 9.64% of the glomerular cell population, with macrophages being the predominant subset. While there was no significant difference in the overall percentage of immune cells across glomeruli exhibiting different pathological features, including mesangial proliferation, global sclerosis, segmental sclerosis and crescents, the infiltration pattern of these cells was distinct. Neighbourhood analysis revealed that the interaction mode of M1-like macrophages varied significantly among these four glomerular pathology types. Severe IgAN (Lee grades IV–V) was associated with a lower glomerular M1/M2-like macrophage infiltration ratio compared to mild IgAN (Lee grade III). The M1/M2-like macrophage ratio positively correlated with the estimated glomerular filtration rate (eGFR), while M2-like macrophages correlated with proteinuria, and T cells were associated with haematuria.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our study findings underscore that glomerular immune cell subtypes and their interaction patterns critically influence pathological and clinical outcomes, suggesting a new potential direction for molecular therapeutic strategies targeting the IgAN microenvironment.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70088","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147614853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integration of single-cell and bulk transcriptomics reveals the association of manganese metabolism-related genes with prognosis and immune infiltration in lung adenocarcinoma 单细胞和整体转录组学的整合揭示了锰代谢相关基因与肺腺癌预后和免疫浸润的关联
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-11 DOI: 10.1002/cti2.70085
Hongliang Li, Shuzhen Wei, Wei Li, Junxia Sun, Yi Wang
{"title":"Integration of single-cell and bulk transcriptomics reveals the association of manganese metabolism-related genes with prognosis and immune infiltration in lung adenocarcinoma","authors":"Hongliang Li,&nbsp;Shuzhen Wei,&nbsp;Wei Li,&nbsp;Junxia Sun,&nbsp;Yi Wang","doi":"10.1002/cti2.70085","DOIUrl":"https://doi.org/10.1002/cti2.70085","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Lung adenocarcinoma (LUAD) is associated with a poor prognosis. Manganese metabolism plays a critical role in antitumor immunity. The prognostic significance of manganese metabolism–related genes (MRGs) in LUAD remains unclear.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Single-cell RNA sequencing and TCGA transcriptomic data were integrated to identify expressed MRGs. Cell subpopulations were defined using AUCell scoring. A prognostic signature was constructed using univariate Cox regression, LASSO regression and multivariate Cox analysis. A nomogram incorporating the manganese metabolism–related risk score (MRS) and clinical variables was developed, and predictive performance was evaluated using receiver operating characteristic curves. Immune infiltration patterns and drug sensitivity were further analysed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A robust prognostic model based on nine genes, including KLRF1, demonstrated strong predictive performance. Patients in the high-MRS group exhibited increased M1 macrophage infiltration and shorter overall survival, whereas the low-MRS group was characterised by enrichment of resting dendritic cells. Drug sensitivity analyses suggested that JQ1 and Vorinostat may be more effective in low-MRS patients, while Pevonedistat and LCL161 may be preferable for high-MRS patients. <i>In vitro</i> experiments confirmed that high PTMA expression promoted malignant phenotypes in LUAD cells, and that combined JQ1 treatment and PTMA knockdown exerted synergistic antitumor effects.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We established and validated a prognostic signature based on nine MRGs. The synergistic antitumor effects of JQ1 and PTMA suppression were verified. This model provides a novel biomarker framework and therapeutic guidance for prognostic assessment and personalised treatment in LUAD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.70085","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147614827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza virus infection drives upregulation of CD84 across a broad range of immune cells 流感病毒感染在广泛的免疫细胞中驱动CD84的上调。
IF 3.8 2区 医学
Clinical & Translational Immunology Pub Date : 2026-03-09 DOI: 10.1002/cti2.70087
Xiaoxiao Jia, Isabelle JH Foo, Hayley A McQuilten, Jeremy Chase Crawford, Aira F Cabug, Deborah Gebregzabher, Janet Chou, Robert C Mettelman, Tanya Novak, Lee-Ann Van de Velde, Ryan S Thwaites, Adrienne G Randolph, Paul G Thomas, Jianqing Xu, Zhongfang Wang, Katherine Kedzierska, Lukasz Kedzierski, Brendon Y Chua
{"title":"Influenza virus infection drives upregulation of CD84 across a broad range of immune cells","authors":"Xiaoxiao Jia,&nbsp;Isabelle JH Foo,&nbsp;Hayley A McQuilten,&nbsp;Jeremy Chase Crawford,&nbsp;Aira F Cabug,&nbsp;Deborah Gebregzabher,&nbsp;Janet Chou,&nbsp;Robert C Mettelman,&nbsp;Tanya Novak,&nbsp;Lee-Ann Van de Velde,&nbsp;Ryan S Thwaites,&nbsp;Adrienne G Randolph,&nbsp;Paul G Thomas,&nbsp;Jianqing Xu,&nbsp;Zhongfang Wang,&nbsp;Katherine Kedzierska,&nbsp;Lukasz Kedzierski,&nbsp;Brendon Y Chua","doi":"10.1002/cti2.70087","DOIUrl":"10.1002/cti2.70087","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Our previous study in hospitalised patients infected with avian A(H7N9) influenza virus identified <i>CD84</i> amongst several genes associated with recovery. Yet, the correlation between CD84 and respiratory viral infection outcomes is far from established. We aimed to define CD84 dynamics in patient cohorts of respiratory disease and immune cell populations in influenza virus-infected mice.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Expression dynamics of <i>CD84</i> and association with previously identified correlates of severe and fatal respiratory disease outcomes, <i>OLAH</i> and <i>IL18R1</i>, were analysed in A(H7N9) and COVID-19 patient cohorts across disease severities. Using mouse models of influenza virus infection, CD84 expression on immune cell subsets was analysed over the course of infection.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Elevated <i>CD84</i> levels in recovered A(H7N9) patients were accompanied by increased expression of genes for CD84-associated adaptor proteins and other SLAM receptor family members. In these patients, high <i>CD84</i> expression persisted until discharge, while remaining low throughout the disease in patients that succumbed. We found inverse correlations between <i>CD84</i> with <i>OLAH</i> and <i>IL18R1</i> levels in our A(H7N9) cohort, and in hospitalised COVID-19 patients across respiratory disease severities. In influenza virus-infected mice, CD84 was upregulated on a broad range of immune cell populations, particularly on activated and influenza virus-specific T-cell populations and correlated with less disease severity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our findings revealed the link between high CD84 expression in humans and recovery from respiratory viral infections. In mice, CD84 expression increased across a broad range of immune cell populations, with CD84 expression on activated T-cell populations correlating with less severe disease.</p>\u0000 </section>\u0000 </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"15 3","pages":""},"PeriodicalIF":3.8,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12971607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147429472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书